NH, A., HM, A., NR, H., AI, A., AK, A., TS, W., & GE, B. (2026). Repurposing of doxycycline as a novel therapeutic avenue for management of parkinson's disease. Inflammopharmacology, 34(5), 3193. https://doi.org/10.1007/s10787-026-02156-y
Chicago Style (17th ed.) CitationNH, Ali, Al-Kuraishy HM, Hussain NR, Al-Gareeb AI, Albuhadily AK, Waheeb TS, and Batiha GE. "Repurposing of Doxycycline as a Novel Therapeutic Avenue for Management of Parkinson's Disease." Inflammopharmacology 34, no. 5 (2026): 3193. https://doi.org/10.1007/s10787-026-02156-y.
MLA (9th ed.) CitationNH, Ali, et al. "Repurposing of Doxycycline as a Novel Therapeutic Avenue for Management of Parkinson's Disease." Inflammopharmacology, vol. 34, no. 5, 2026, p. 3193, https://doi.org/10.1007/s10787-026-02156-y.